Static Chart Monte Rosa Therapeutics, Inc.

Stocks

Market Closed - Nasdaq 21:00:00 16/10/2026 BST			5-day change	1st Jan Change
9.740 ^USD	-3.75%		-5.62%	-37.88%

10-12	UBS Adjusts Price Target on Monte Rosa Therapeutics to $19 From $17, Maintains Buy Rating	MT
10-01	Monte Rosa Therapeutics Announces Positive Data From GFORCE-1 Phase 1 Study Evaluating MRT-8102	CI

Duration

Period